Eur J Pediatr Surg 2024; 34(01): 028-035
DOI: 10.1055/s-0043-1771225
Original Article

A History of Umbilical Vein Catheterization Does Not Preclude Children from a Successful Meso-Rex Bypass

1   Division of Transplant and Advanced Hepatobiliary Surgery, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
,
Stephanie Yang
1   Division of Transplant and Advanced Hepatobiliary Surgery, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
,
Katherine A. Brandt
1   Division of Transplant and Advanced Hepatobiliary Surgery, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
,
Sydney Carra
1   Division of Transplant and Advanced Hepatobiliary Surgery, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
,
Riccardo A. Superina
1   Division of Transplant and Advanced Hepatobiliary Surgery, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
› Institutsangaben
Funding We acknowledge the support from the Robert E. Schneider Foundation in conducting the research for this work.

Abstract

Introduction Umbilical vein catheterization (UVC) can cause portal venous thrombosis, leading to the development of extrahepatic portal venous obstruction (EHPVO) and portal hypertension (PHT). The feasibility of the Meso-Rex bypass (MRB) for the treatment of EHPVO in patients with a history of UVC has been questioned. We compared the feasibility of performing an MRB in patients with or without a history of previous UVC.

Methods A retrospective review of patients with EHPVO and known UVC status explored for a possible MRB at our institution was performed (1997–2022). Patients were categorized in two groups: with (UVC(+)) or without (UVC(–)) a history of UVC for comparison. A p-value less than 0.05 was considered significant.

Results One hundred and eighty-seven patients were included (n = 57 in UVC(+); n = 130 in UVC(–)). Patients in the UVC group were significantly younger at surgery and the incidence of prematurity was higher. Other risk factors for the development of EHPVO were similar between the groups, but only history of UVC could predict the ability to receive MRB (odds ratio [OR]: 7.4 [3.5–15.4]; p < 0.001). The success rate of MRB was significantly higher in patients with no history of UVC (28/57 [49.1%] in UVC(+) vs. 114/130 [87.7%] in UVC(–); p < 0.001). However, MRB patency at discharge (25/28 [89.3%] in UVC(+) vs. 106/114 [94.7%] in UVC(–); p = 0.3) was equally high in both groups.

Conclusion Our results indicate that a history of UVC is not a contraindication to MRB. Half of the patients were able to successfully receive an MRB. Patients with symptomatic PHT from EHPVO should not be excluded from consideration for MRB based on UVC history.



Publikationsverlauf

Eingereicht: 08. Mai 2023

Angenommen: 16. Juni 2023

Artikel online veröffentlicht:
24. Juli 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Shneider BL, de Ville de Goyet J, Leung DH. et al. Primary prophylaxis of variceal bleeding in children and the role of MesoRex bypass: summary of the Baveno VI Pediatric Satellite Symposium. Hepatology 2016; 63 (04) 1368-1380
  • 2 Superina RA, Alonso EM. Medical and surgical management of portal hypertension in children. Curr Treat Options Gastroenterol 2006; 9 (05) 432-443
  • 3 Pietrobattista A, Luciani M, Abraldes JG. et al. Extrahepatic portal vein thrombosis in children and adolescents: influence of genetic thrombophilic disorders. World J Gastroenterol 2010; 16 (48) 6123-6127
  • 4 Cabannes M, Bouissou A, Favrais G. et al. Systematic ultrasound examinations in neonates admitted to NICU: evolution of portal vein thrombosis. J Perinatol 2018; 38 (10) 1359-1364
  • 5 Bersani I, Piersigilli F, Iacona G. et al. Incidence of umbilical vein catheter-associated thrombosis of the portal system: a systematic review and meta-analysis. World J Hepatol 2021; 13 (11) 1802-1815
  • 6 Morag I, Epelman M, Daneman A. et al. Portal vein thrombosis in the neonate: risk factors, course, and outcome. J Pediatr 2006; 148 (06) 735-739
  • 7 Sobczak A, Kruczek P, Homa M, Kwinta P. A new microscopic insight into the thrombogenicity of umbilical catheters. Thromb Res 2018; 168: 80-82
  • 8 de Ville de Goyet J, Clapuyt P, Otte JB. Extrahilar mesenterico-left portal shunt to relieve extrahepatic portal hypertension after partial liver transplant. Transplantation 1992; 53 (01) 231-232
  • 9 Sharif K, McKiernan P, de Ville de Goyet J. Mesoportal bypass for extrahepatic portal vein obstruction in children: close to a cure for most!. J Pediatr Surg 2010; 45 (01) 272-276
  • 10 di Francesco F, Grimaldi C, de Ville de Goyet J. Meso-Rex bypass: a procedure to cure prehepatic portal hypertension: the insight and the inside. J Am Coll Surg 2014; 218 (02) e23-e36
  • 11 Bertocchini A, Falappa P, Grimaldi C, Bolla G, Monti L, de Ville de Goyet J. Intrahepatic portal venous systems in children with noncirrhotic prehepatic portal hypertension: anatomy and clinical relevance. J Pediatr Surg 2014; 49 (08) 1268-1275
  • 12 Gibelli NE, Tannuri AC, Pinho-Apezzato ML, Maksoud-Filho JG, Tannuri U. Extrahepatic portal vein thrombosis after umbilical catheterization: is it a good choice for Rex shunt?. J Pediatr Surg 2011; 46 (01) 214-216
  • 13 Guérin F, Bidault V, Gonzales E, Franchi-Abella S, De Lambert G, Branchereau S. Meso-Rex bypass for extrahepatic portal vein obstruction in children. Br J Surg 2013; 100 (12) 1606-1613
  • 14 Chin AC, Thow F, Superina RA. Previous portal hypertension surgery negatively affects results of mesenteric to left portal vein bypass. J Pediatr Surg 2008; 43 (01) 114-119 , discussion 119
  • 15 Superina R, Bambini DA, Lokar J, Rigsby C, Whitington PF. Correction of extrahepatic portal vein thrombosis by the mesenteric to left portal vein bypass. Ann Surg 2006; 243 (04) 515-521
  • 16 Khamag O, Numanoglu A, Rode H, Millar A, Cox S. Surgical management of extrahepatic portal vein obstruction in children: advantages of MesoRex shunt compared with distal splenorenal shunt. Pediatr Surg Int 2023; 39 (01) 128
  • 17 Lautz TB, Keys LA, Melvin JC, Ito J, Superina RA. Advantages of the meso-Rex bypass compared with portosystemic shunts in the management of extrahepatic portal vein obstruction in children. J Am Coll Surg 2013; 216 (01) 83-89
  • 18 Lautz TB, Sundaram SS, Whitington PF, Keys L, Superina RA. Growth impairment in children with extrahepatic portal vein obstruction is improved by mesenterico-left portal vein bypass. J Pediatr Surg 2009; 44 (11) 2067-2070
  • 19 Mack CL, Zelko FA, Lokar J. et al. Surgically restoring portal blood flow to the liver in children with primary extrahepatic portal vein thrombosis improves fluid neurocognitive ability. Pediatrics 2006; 117 (03) e405-e412
  • 20 Zielsdorf S, Narayanan L, Kantymyr S. et al. Surgical shunts for extrahepatic portal vein obstruction in pediatric patients: a systematic review. HPB (Oxford) 2021; 23 (05) 656-665
  • 21 Yamoto M, Chusilp S, Alganabi M, Sayed BA, Pierro A. Meso-Rex bypass versus portosystemic shunt for the management of extrahepatic portal vein obstruction in children: systematic review and meta-analysis. Pediatr Surg Int 2021; 37 (12) 1699-1710
  • 22 Kim JH, Lee YS, Kim SH, Lee SK, Lim MK, Kim HS. Does umbilical vein catheterization lead to portal venous thrombosis? Prospective US evaluation in 100 neonates. Radiology 2001; 219 (03) 645-650